VBSHealth CareCompany Update30 Sept 202630 September 2026· 2 min read
Vectus Biosystems (ASX: VBS) Granted FDA Pre-IND Meeting for VB0004
Vectus Biosystems has secured an FDA pre-IND meeting for lead fibrosis candidate VB0004. Written guidance expected by mid-November 2026 will inform the program’s next steps.